Home > Insider Trading > Filing (0001192482-19-000271)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1588972	Recro Pharma Inc.	REPH	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1293424	Arnaud Ajdler	C/O Recro Pharma, Inc. 490 Lapp Road Malvern PA 19355		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-05-17	40,000	$9.00	1,104,546	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnote

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	7,955	Direct

Footnotes

The Reporting Person is the managing partner of Engine Capital Management, LP ("Engine Management") and the Managing Member of each of Engine Capital Management GP, LLC ("Engine Management GP") and Engine Investments, LLC ("Engine Investments"). Engine Capital Management GP is the investment manager of Engine Capital, L.P. ("Engine Capital") and Engine Jet Capital, L.P. ("Engine Jet Capital"). In the transaction, Engine Capital and Engine Jet Capital acquired 26,568 and 13,432 shares of the Issuer's common stock, respectively. Following the transaction, Engine Capital owns 907,578 shares and Engine Jet Capital owns 196,968 shares of the Issuer's common stock. The Reporting Person disclaims beneficial ownership in such securities except to the extent of his pecuniary interest therein.
All shares of common stock are represented by unvested restricted stock units that will vest on May 9, 2020. Vested shares will be delivered to the reporting person within 30 days following the vesting date.